D., Satylganova, A., Skovgaard, D., & McGowan, B
History of Type 2 Diabetes or Obesity You may also be eligible for GLP-1 treatment if you have a medical history of type 2 diabetes, heart disease, or both
During that same call, Eli Lilly said it expected sales of Trulicity and some other drugs it makes to level off, saying Flat or eroding contributions from later lifecycle products including Taltz, Trulicity, and Verzenio. Eli Lilly faces dozens of lawsuits filed by patients who say they took Trulicity and suffered from complications like ileus, gastroparesis, and pancreatitis
48 It exerts neuroprotective and neurotrophic effects, including BDNF upregulation and synaptogenesis
Injectable Pen Segment is Expected to Drive the GLP-1 Drug Biosimilar Market The market share of the Injectable Pen segment was the largest in 2025